Euglena holds an R&D study session

▤ Summary

Euglena held an R&D briefing for media and outlined how it will shift its research organization starting in 2026. The company emphasized a new approach that combines biology and chemistry to expand the use of microalgae-derived ingredients. It highlighted paramylon research, possible applications in food and cosmetics, and a new research effort targeting chronic kidney disease. The company also said it will pursue external partnerships with businesses and medical institutions to validate research and speed up commercialization.

▦ Linked Companies